Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Feb 10, 2020
On a summer’s evening, a picnic was being held on the lawn of the White House with President Trump and his inner circle. It should have been a day of celebration, but as the TV cameras filmed the mingling guests, a Republican Congressman and prominent Trump ally was pacing up and down on his phone. He’d just discovered his multi-million-dollar investment in an obscure Australian biotech firm was about to tank.
Congressman Chris Collins was a long-time investor and board member of a Sydney-based company engaged in therapeutic drug development. On that fateful evening, he received confidential information that a crucial drug trial had failed, and his investment was at risk. What happened next would destroy his career and land him in prison.